We are emerging markets transaction advisors. Learn more about our exceptional staff and unprecedented level of expertise.
 

Transactions

Garmisch Pharmaceutical

Divestiture to Mega Pharma

Undisclosed

January 2017

Colombia

Sinclair IS Pharma

Licensing of Ellanse and Silhouette to PharmaVital

Undisclosed

March 2015

Central America and Colombia

Comedix

Sale of Laboratoire Obvieline to Sinclair IS Pharma

€ 35 million

January 2014

Europe, Latin America, Asia Pacific

Sinclair IS Pharma

Licensing of Kelo Cote and Perfectha to PharmaVital

Undisclosed

January 2014

Central America

Biotoscana

Acquisition of United Medical

Undisclosed

January 2014

Brazil

Lafrancol S.A.

Divestiture to CFR Pharmaceutical S.A.

$ 562 million

August 2012

Colombia

Merck Serono

Strategic Alliance on Floratil

Undisclosed

February 2012

Brazil

Ferring

Licensing of Euflexxa to UCB

Undisclosed

December 2010

Brazil

Bristol-Myers Squibb

Outsourcing of distribution and promotion of mature brands portfolio

$ 500 million

May 2008

Latin America

Bristol-Myers Squibb

Sale of Sefril Trademark to Urufarma

$ 1 million

April 2008

Uruguay